Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.).

Zhao, Tie; Peng, Liang

Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.).

Zhao, Tie; Peng, Liang.

Zhao T; Institute of Pathogenic Biology and Key Laboratory of Special Pathogen Prevention and Control of Hunan Province, Hengyang Medical College, University of South China, Hengyang, 421001, China.
Peng L; Guangzhou Key Laboratory of Enhanced Recovery After Abdominal Surgery, Department of Clinical Laboratory, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510700, China. Electronic address: nhdxzhfj@163.com.

Diabetes Metab Syndr ; 15(1): 21, 2021.

Article in English | MEDLINE | ID: covidwho-1065019

Subject(s)

COVID-19; Coronavirus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Coronavirus / Hydroxymethylglutaryl-CoA Reductase Inhibitors / COVID-19 Limits: Humans Language: English Journal: Diabetes Metab Syndr Year: 2021 Document Type: Article Affiliation country: J.dsx.2020.11.017

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google